Little Boxes of Hope

Little Boxes of HopeLittle Boxes of HopeLittle Boxes of Hope

Little Boxes of Hope

Little Boxes of HopeLittle Boxes of HopeLittle Boxes of Hope
  • Home
  • Welcome
  • About us
  • Our Patients' Stories
  • Testimonials
  • Press Releases
  • How can you help?
  • Contact Us
  • More
    • Home
    • Welcome
    • About us
    • Our Patients' Stories
    • Testimonials
    • Press Releases
    • How can you help?
    • Contact Us
  • Home
  • Welcome
  • About us
  • Our Patients' Stories
  • Testimonials
  • Press Releases
  • How can you help?
  • Contact Us

CASE HISTORY

This 2-year-old boy from Venezuela presented with a large right neck soft tissue mass.

Histopathology

 A biopsy was performed. The tumor was initially thought to represent classic Hodgkin lymphoma. Given the unusual age for this diagnosis, it was subsequently submitted via courier for a second opinion.

Histopathology

Histopathology

Histopathology

Medium power view shows a soft tissue mass composed of spindle (elongated) cells arranged in intersecting fascicles, in a focally sclerotic appearing stroma.

Histopathology

Histopathology

Histopathology

Higher power view shows moderately atypical cells containing irregular nuclei with open vesicular chromatin and occasional prominent nucleoli.

Histopathology

Immunohistochemistry (SMA)

Histopathology

In areas, a mixed inflammatory background containing abundant eosinophils, plasma cells, lymphocytes and neutrophils was noticed.

Immunohistochemistry (SMA)

Histopathology

In view of these histologic findings, an inflammatory myofibroblastic tumor was strongly suspected. The diagnosis was further confirmed by the expression of smooth muscle actin (SMA) and ALK. 

Immunohistochemistry (SMA)

Immunohistochemistry (SMA)

Immunohistochemistry (SMA)

Immunohistochemistry (ALK)

Immunohistochemistry (ALK)

Immunohistochemistry (SMA)

Immunohistochemistry (ALK)

Following his revised diagnosis, the patient underwent surgery alone to remove his tumor, obviating a need for chemo and/or radiotherapy at this time. In addition, given its underlying molecular rearrangement involving the ALK1 gene, these tumors can be potentially treated with targeted therapies (i.e. tyrosine kinase inhibitors), if they don't respond to conventional treatments following their recurrence.

Immunohistochemistry (ALK)

Go back to our patients' stories

Copyright © 2024 Little Boxes of Hope - All Rights Reserved.

Powered by GoDaddy

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept